GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societal CDMO Inc (FRA:RAH) » Definitions » Shiller PE Ratio

Societal CDMO (FRA:RAH) Shiller PE Ratio : (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Societal CDMO Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Societal CDMO Shiller PE Ratio Historical Data

The historical data trend for Societal CDMO's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Societal CDMO Shiller PE Ratio Chart

Societal CDMO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Societal CDMO Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Societal CDMO's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Societal CDMO's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Societal CDMO's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Societal CDMO's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Societal CDMO's Shiller PE Ratio falls into.



Societal CDMO Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Societal CDMO's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Societal CDMO's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/129.4194*129.4194
=0.000

Current CPI (Dec. 2023) = 129.4194.

Societal CDMO Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -2.653 99.695 -3.444
201406 -0.265 100.560 -0.341
201409 -0.473 100.428 -0.610
201412 -0.365 99.070 -0.477
201503 -0.490 99.621 -0.637
201506 -0.151 100.684 -0.194
201509 -0.214 100.392 -0.276
201512 1.037 99.792 1.345
201603 -0.638 100.470 -0.822
201606 -0.739 101.688 -0.941
201609 -0.445 101.861 -0.565
201612 -0.768 101.863 -0.976
201703 -0.393 102.862 -0.494
201706 -0.427 103.349 -0.535
201709 -0.403 104.136 -0.501
201712 -1.073 104.011 -1.335
201803 -0.527 105.290 -0.648
201806 -0.531 106.317 -0.646
201809 -0.548 106.507 -0.666
201812 -1.688 105.998 -2.061
201903 -0.089 107.251 -0.107
201906 -0.115 108.070 -0.138
201909 -0.173 108.329 -0.207
201912 -0.378 108.420 -0.451
202003 -0.299 108.902 -0.355
202006 -0.222 108.767 -0.264
202009 -0.076 109.815 -0.090
202012 -0.395 109.897 -0.465
202103 -0.193 111.754 -0.224
202106 0.025 114.631 0.028
202109 -0.060 115.734 -0.067
202112 -0.035 117.630 -0.039
202203 -0.073 121.301 -0.078
202206 -0.057 125.017 -0.059
202209 -0.061 125.227 -0.063
202212 -0.142 125.222 -0.147
202303 -0.056 127.348 -0.057
202306 -0.037 128.729 -0.037
202309 -0.047 129.860 -0.047
202312 0.000 129.419 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Societal CDMO  (FRA:RAH) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Societal CDMO Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Societal CDMO's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Societal CDMO (FRA:RAH) Business Description

Traded in Other Exchanges
Address
1 E. Uwchlan Avenue, Suite 112, Exton, PA, USA, 19341
Societal CDMO Inc is a bi-coastal contract development and manufacturing organization. It offers capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms primarily focused on small molecules. The company also provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics services to the global pharmaceutical market.

Societal CDMO (FRA:RAH) Headlines

No Headlines